Annual Retained Earnings
-$297.25 M
-$7.71 M-2.66%
December 31, 2023
Summary
- As of March 13, 2025, TENX annual retained earnings is -$297.25 million, with the most recent change of -$7.71 million (-2.66%) on December 31, 2023.
- During the last 3 years, TENX annual retained earnings has fallen by -$51.23 million (-20.82%).
- TENX annual retained earnings is now -4561.47% below its all-time high of -$6.38 million, reached on April 30, 1996.
Performance
TENX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$308.59 M
-$3.96 M-1.30%
September 30, 2024
Summary
- As of March 13, 2025, TENX quarterly retained earnings is -$308.59 million, with the most recent change of -$3.96 million (-1.30%) on September 30, 2024.
- Over the past year, TENX quarterly retained earnings has dropped by -$7.54 million (-2.50%).
- TENX quarterly retained earnings is now -2811.20% below its all-time high of -$10.60 million, reached on July 31, 1999.
Performance
TENX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TENX Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.7% | -2.5% |
3 y3 years | -20.8% | -5.7% |
5 y5 years | -30.5% | -5.7% |
TENX Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -6.7% | at low | -10.8% | at low |
5 y | 5-year | -25.9% | at low | -30.7% | at low |
alltime | all time | -4561.5% | at low | -2811.2% | at low |
Tenax Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$308.59 M(+1.3%) |
Jun 2024 | - | -$304.63 M(+1.2%) |
Mar 2024 | - | -$301.05 M(+1.3%) |
Dec 2023 | -$297.25 M(+2.7%) | -$297.25 M(+1.1%) |
Sep 2023 | - | -$294.03 M(+0.7%) |
Jun 2023 | - | -$292.06 M(+0.4%) |
Mar 2023 | - | -$290.95 M(+0.5%) |
Dec 2022 | -$289.54 M(+4.0%) | -$289.54 M(+0.9%) |
Sep 2022 | - | -$286.99 M(+1.0%) |
Jun 2022 | - | -$284.08 M(+1.0%) |
Mar 2022 | - | -$281.22 M(+1.0%) |
Dec 2021 | -$278.49 M(+13.2%) | -$278.49 M(+1.2%) |
Sep 2021 | - | -$275.28 M(+1.4%) |
Jun 2021 | - | -$271.49 M(+0.6%) |
Mar 2021 | - | -$269.77 M(+9.7%) |
Dec 2020 | -$246.02 M(+4.2%) | -$246.02 M(+1.2%) |
Sep 2020 | - | -$243.19 M(+0.9%) |
Jun 2020 | - | -$240.97 M(+0.9%) |
Mar 2020 | - | -$238.82 M(+1.1%) |
Dec 2019 | -$236.17 M(+3.7%) | -$236.17 M(+1.2%) |
Sep 2019 | - | -$233.38 M(+1.0%) |
Jun 2019 | - | -$231.15 M(+0.8%) |
Mar 2019 | - | -$229.39 M(+0.7%) |
Dec 2018 | -$227.80 M(+6.7%) | -$227.80 M(+4.5%) |
Sep 2018 | - | -$218.08 M(+0.7%) |
Jun 2018 | - | -$216.55 M(+0.9%) |
Mar 2018 | - | -$214.68 M(+0.6%) |
Dec 2017 | -$213.50 M(+4.3%) | -$213.50 M(+0.6%) |
Sep 2017 | - | -$212.16 M(+0.6%) |
Jun 2017 | - | -$210.92 M(+1.4%) |
Mar 2017 | - | -$207.94 M(+1.6%) |
Dec 2016 | -$204.66 M(+27.3%) | -$204.66 M(+16.9%) |
Sep 2016 | - | -$175.01 M(+2.5%) |
Jun 2016 | - | -$170.74 M(+2.8%) |
Mar 2016 | - | -$166.10 M(+5.6%) |
Dec 2015 | -$160.74 M(+6.7%) | - |
Oct 2015 | - | -$157.23 M(+2.3%) |
Jul 2015 | - | -$153.70 M(+2.0%) |
Apr 2015 | -$150.67 M(+10.3%) | -$150.67 M(+3.4%) |
Jan 2015 | - | -$145.68 M(+2.0%) |
Oct 2014 | - | -$142.81 M(+2.9%) |
Jul 2014 | - | -$138.76 M(+1.6%) |
Apr 2014 | -$136.59 M(+16.7%) | -$136.59 M(+8.3%) |
Jan 2014 | - | -$126.17 M(+2.7%) |
Oct 2013 | - | -$122.82 M(+3.0%) |
Jul 2013 | - | -$119.29 M(+1.9%) |
Apr 2013 | -$117.04 M(+8.7%) | -$117.04 M(+1.6%) |
Jan 2013 | - | -$115.19 M(+2.1%) |
Oct 2012 | - | -$112.77 M(+1.4%) |
Jul 2012 | - | -$111.21 M(+3.3%) |
Apr 2012 | -$107.63 M | -$107.63 M(+2.5%) |
Jan 2012 | - | -$105.01 M(+7.5%) |
Oct 2011 | - | -$97.71 M(+3.1%) |
Date | Annual | Quarterly |
---|---|---|
Jul 2011 | - | -$94.79 M(+3.1%) |
Apr 2011 | -$91.92 M(+12.8%) | -$91.92 M(+3.2%) |
Jan 2011 | - | -$89.07 M(+2.9%) |
Oct 2010 | - | -$86.52 M(+2.4%) |
Jul 2010 | - | -$84.47 M(+3.7%) |
Apr 2010 | -$81.47 M(+14.8%) | -$81.47 M(+3.5%) |
Jan 2010 | - | -$78.70 M(+3.6%) |
Oct 2009 | - | -$75.95 M(+3.5%) |
Jul 2009 | - | -$73.36 M(+3.4%) |
Apr 2009 | -$70.96 M(+88.0%) | -$70.96 M(+30.8%) |
Jan 2009 | - | -$54.26 M(+18.2%) |
Oct 2008 | - | -$45.90 M(+9.3%) |
Jul 2008 | - | -$41.99 M(+11.3%) |
Apr 2008 | -$37.74 M(+21.7%) | -$37.74 M(+6.9%) |
Jan 2008 | - | -$35.30 M(+7.1%) |
Oct 2007 | - | -$32.98 M(+2.9%) |
Jul 2007 | - | -$32.05 M(+3.3%) |
Apr 2007 | -$31.02 M(+12.0%) | -$31.02 M(+3.4%) |
Jan 2007 | - | -$29.99 M(+3.1%) |
Oct 2006 | - | -$29.10 M(+2.4%) |
Jul 2006 | - | -$28.40 M(+2.6%) |
Apr 2006 | -$27.69 M(+17.2%) | -$27.69 M(+3.4%) |
Jan 2006 | - | -$26.77 M(+3.3%) |
Oct 2005 | - | -$25.91 M(+6.9%) |
Jul 2005 | - | -$24.24 M(+2.6%) |
Apr 2005 | -$23.62 M(+12.8%) | -$23.62 M(+3.1%) |
Jan 2005 | - | -$22.91 M(+4.0%) |
Oct 2004 | - | -$22.02 M(+2.8%) |
Jul 2004 | - | -$21.42 M(+2.3%) |
Apr 2004 | -$20.95 M(+12.0%) | -$20.95 M(+2.6%) |
Jan 2004 | - | -$20.43 M(+4.1%) |
Oct 2003 | - | -$19.61 M(+2.4%) |
Jul 2003 | - | -$19.15 M(+2.4%) |
Apr 2003 | -$18.70 M(+13.5%) | -$18.70 M(+1.8%) |
Jan 2003 | - | -$18.37 M(+2.6%) |
Oct 2002 | - | -$17.90 M(+6.1%) |
Jul 2002 | - | -$16.87 M(+2.4%) |
Apr 2002 | -$16.47 M(+26.9%) | -$16.47 M(+13.6%) |
Jan 2002 | - | -$14.51 M(+3.4%) |
Oct 2001 | - | -$14.02 M(+3.9%) |
Jul 2001 | - | -$13.50 M(+4.0%) |
Apr 2001 | -$12.99 M(+14.8%) | -$12.99 M(+4.0%) |
Jan 2001 | - | -$12.48 M(+3.4%) |
Oct 2000 | - | -$12.08 M(+4.4%) |
Jul 2000 | - | -$11.57 M(+2.2%) |
Apr 2000 | -$11.31 M(+8.8%) | -$11.31 M(+2.8%) |
Jan 2000 | - | -$11.00 M(+1.9%) |
Oct 1999 | - | -$10.80 M(+1.9%) |
Jul 1999 | - | -$10.60 M |
Apr 1999 | -$10.40 M(+8.7%) | - |
Apr 1998 | -$9.57 M(+15.5%) | - |
Apr 1997 | -$8.29 M(+30.0%) | - |
Apr 1996 | -$6.38 M | - |
FAQ
- What is Tenax Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Tenax Therapeutics?
- What is Tenax Therapeutics annual retained earnings year-on-year change?
- What is Tenax Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly retained earnings year-on-year change?
What is Tenax Therapeutics annual retained earnings?
The current annual retained earnings of TENX is -$297.25 M
What is the all time high annual retained earnings for Tenax Therapeutics?
Tenax Therapeutics all-time high annual retained earnings is -$6.38 M
What is Tenax Therapeutics annual retained earnings year-on-year change?
Over the past year, TENX annual retained earnings has changed by -$7.71 M (-2.66%)
What is Tenax Therapeutics quarterly retained earnings?
The current quarterly retained earnings of TENX is -$308.59 M
What is the all time high quarterly retained earnings for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly retained earnings is -$10.60 M
What is Tenax Therapeutics quarterly retained earnings year-on-year change?
Over the past year, TENX quarterly retained earnings has changed by -$7.54 M (-2.50%)